Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patients

Documenti analoghi

• Improving cefazolin exposure in critically ill children using a population pharmacokinetic model
  di: Clémence Rivaud, et al.
  Pubblicazione: (2024)
• Population pharmacokinetics of TBAJ‐587 and its main metabolites—Evaluation of different loading dose strategies and early dose selection
  di: Albin A. M. Leding, et al.
  Pubblicazione: (2025)
• Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin‐resistant tuberculosis
  di: Megan Palmer, et al.
  Pubblicazione: (2025)
• Temporal effects of errors in estimating kidney function after critical illness on drug dosing categories
  di: Ryusei Mikami, et al.
  Pubblicazione: (2025)
• Population pharmacokinetics of high‐dose methotrexate and 7‐hydroxy methotrexate in Chinese adults with primary central nervous system lymphoma
  di: Ruoyun Wu, et al.
  Pubblicazione: (2025)